Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives $123.80 Average PT from Analysts
Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation and nine have assigned a buy recommendation to the company. The average twelve-month […]
Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation and nine have assigned a buy recommendation to the company. The average twelve-month […]
